☆ 4.7 Article

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity

Habib Yaribeygi et al.

Summary: Epicardial adipose tissue plays a physiological role in normal heart function, but can become a cardiac risk factor in pathological conditions. Recent studies suggest that SGLT2 inhibitors can modulate epicardial adiposity and reduce the risk of cardiac complications in diabetic patients.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1

Fatma Abdel-Azim Sanad et al.

Summary: The study demonstrates the potential of Solidago virgaurea extract in reducing blood glucose and serum lipid levels, supporting its use as an ethnomedicinal treatment for diabetes mellitus and hyperlipidemia.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Obesity and Insulin Resistance Is the Component of the Metabolic Syndrome Most Strongly Associated with Oxidative Stress

Grzegorz K. Jakubiak et al.

Summary: Metabolic syndrome is the coexistence of factors that increase the risk for type 2 diabetes and cardiovascular disease, and it is associated with oxidative stress. Among the components of metabolic syndrome, obesity and insulin resistance show the strongest association with oxidative stress.

ANTIOXIDANTS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

Teresa Salvatore et al.

Summary: SGLT2 inhibitors play a critical role in glycemic regulation in diabetes and also prevent damage to the heart and kidneys. In addition to their target effects, SGLT2 inhibitors have beneficial actions on various pathways, including improving cardiac metabolism and regulating load conditions in the heart and kidneys.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease

Riccardo Nevola et al.

Summary: Type 2 diabetes mellitus is linked to an increased occurrence of cardiovascular and renal diseases. The availability of new drugs, particularly sodium-glucose cotransporter-2 inhibitors, has revolutionized the treatment of T2DM by positively impacting the cardiovascular and renal risks. These drugs have shown significant reductions in mortality rates, hospitalization rates, and progression of kidney damage and albuminuria.

REVIEWS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Article Environmental Sciences

Protective effect of empagliflozin on gentamicin-induced acute renal injury via regulation of SIRT1/NF-κB signaling pathway

Sandy R. Botros et al.

Summary: Empagliflozin can alleviate gentamicin-induced nephropathy by reducing oxidative stress, inflammation, and apoptosis, as well as improving tubular regeneration.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2022)

添加到收藏夹

Review Cell Biology

Sodium-glucose co-transporter 2 inhibitors and hematopoiesis

Habib Yaribeygi et al.

Summary: SGLT2 inhibitors may enhance hematopoiesis and stimulate erythropoiesis in diabetic patients, potentially providing additional benefits.

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

添加到收藏夹

Review Environmental Sciences

Endothelial Function Assessment by Flow-Mediated Dilation Method: A Valuable Tool in the Evaluation of the Cardiovascular System

Szymon Mucka et al.

Summary: Assessment of endothelial function, particularly using the non-invasive method of flow-mediated dilation (FMD), is crucial in predicting the risk of cardiovascular diseases.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists

Agata Winiarska et al.

Summary: The incidence of diabetic kidney disease (DKD) in patients with type 2 diabetes is increasing globally. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor (GLP-1R) agonists have been shown to have nephroprotective effects in patients with established DKD, beyond just improving metabolic control of diabetes. The interactions of these agents with inflammation and oxidative stress appear to have a universal mechanism of organ protection in diabetes and other diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Urology & Nephrology

Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage

Peter Kolkhof et al.

Summary: This study compared the effects of nonsteroidal MR antagonist finerenone and SGLT2 inhibitor empagliflozin as monotherapy and in combination in a preclinical model of hypertension-induced cardiorenal disease. The low-dose combination therapy showed superior outcomes in reducing proteinuria, blood pressure, plasma markers, and cardiorenal lesions compared to respective monotherapy dosages.

AMERICAN JOURNAL OF NEPHROLOGY (2021)

添加到收藏夹

Article Biology

Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes

Sadaf Jamal Gilani et al.

Summary: The study revealed that treatment with fustin has a significant protective effect against STZ-induced diabetes, which may become a future option for hyperglycemic treatment. Fustin was shown to prevent changes in body weight, blood glucose, lipid profile, and oxidative stress.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers

Salman Hussain et al.

Summary: Diabetic kidney disease (DKD) is a major public health problem characterized by elevated urine albumin excretion or reduced glomerular filtration rate. The pathophysiology involves various pathways, and timely diagnosis and appropriate interventions are crucial for dealing with this condition.

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Neuromodulatory effects of anti-diabetes medications: A mechanistic review

Habib Yaribeygi et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Review Medicine, General & Internal

Inflammatory Targets in Diabetic Nephropathy

Javier Donate-Correa et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Review Cell Biology

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

Habib Yaribeygi et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)

添加到收藏夹

Review Public, Environmental & Occupational Health

Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis

Majid Mobasseri et al.

HEALTH PROMOTION PERSPECTIVES (2020)

添加到收藏夹

Review Cell Biology

A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress

Habib Yaribeygi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes

Francesca Iannantuoni et al.

JOURNAL OF CLINICAL MEDICINE (2019)

添加到收藏夹

Review Cell Biology

Sodium-glucose cotransporter inhibitors and oxidative stress: An update

Habib Yaribeygi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats

Habib Yaribeygi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy

Habib Yaribeygi et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Oxidative stress induces renal failure: A review of possible molecular pathways

Habib Yaribeygi et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia

Fallon K. Lutchmansingh et al.

PLOS ONE (2018)

添加到收藏夹

Article Geriatrics & Gerontology

Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis

Yuki Kakio et al.

GERIATRICS & GERONTOLOGY INTERNATIONAL (2018)

添加到收藏夹

Article Chemistry, Medicinal

PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System

Habib Yaribeygi et al.

DRUG RESEARCH (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

Sebastian Steven et al.

REDOX BIOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity

Matthias Oelze et al.

PLOS ONE (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy

Masumi Kamiyama et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

添加到收藏夹

Review Physiology

MECHANISMS OF DIABETIC COMPLICATIONS

Josephine M. Forbes et al.

PHYSIOLOGICAL REVIEWS (2013)

添加到收藏夹

Article Peripheral Vascular Disease

Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities

Verena K. Capellini et al.

Current Vascular Pharmacology (2010)

添加到收藏夹

Article Urology & Nephrology

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy

Anders Jorsal et al.

KIDNEY INTERNATIONAL (2008)

添加到收藏夹

Article Cell Biology

Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression:: mRNA and protein expressions of Cu-ZnSOD and catalase

Goekhan Sadi et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)

添加到收藏夹

Article Endocrinology & Metabolism

Risk factors for renal dysfunction in type 2 diabetes - UK prospective diabetes study 74

Ravi Retnakaran et al.

DIABETES (2006)

添加到收藏夹

Article Physiology

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

M Satoh et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)

添加到收藏夹

Article Endocrinology & Metabolism

Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes

D Darmaun et al.

DIABETES (2005)

添加到收藏夹

Article Pharmacology & Pharmacy

Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: Response to insulin and antioxidant therapies

RK Sindhu et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.